These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Peterson EA; Milliron KJ; Lewis KE; Goold SD; Merajver SD Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):79-87. PubMed ID: 11815404 [TBL] [Abstract][Full Text] [Related]
3. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Wang G; Beattie MS; Ponce NA; Phillips KA Genet Med; 2011 Dec; 13(12):1045-50. PubMed ID: 21844812 [TBL] [Abstract][Full Text] [Related]
4. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857 [TBL] [Abstract][Full Text] [Related]
5. [Health risks, heredity screening and insurance]. Arnold IJ; van de Vathorst S Ned Tijdschr Geneeskd; 1991 Mar; 135(11):480-3. PubMed ID: 2023656 [No Abstract] [Full Text] [Related]
6. Medicare-funded cancer genetic tests: a note of caution. Kirk J; Barlow-Stewart KK; Poplawski NK; Gleeson M; Tucker K; Friedlander M Med J Aust; 2018 Aug; 209(5):193-196. PubMed ID: 30157409 [No Abstract] [Full Text] [Related]
7. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Forman AD; Hall MJ Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331 [TBL] [Abstract][Full Text] [Related]
8. Support Access to Genetic Counseling. Terry SF Genet Test Mol Biomarkers; 2021 Jun; 25(6):385-386. PubMed ID: 34152847 [No Abstract] [Full Text] [Related]
9. As genetic tests move into the mainstream, challenges await for doctors and patients. Zielinski SL J Natl Cancer Inst; 2005 Mar; 97(5):334-6. PubMed ID: 15741567 [No Abstract] [Full Text] [Related]
10. Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications. Snyder C Fam Cancer; 2016 Jul; 15(3):493-6. PubMed ID: 26920353 [TBL] [Abstract][Full Text] [Related]
11. The impact of insurance coverage on the prenatal genetic counseling process: An exploration of genetic counselors' experiences with TRICARE. Brown J; O'Neill S; DiNonno W; Hess O Prenat Diagn; 2019 May; 39(6):448-455. PubMed ID: 30883831 [TBL] [Abstract][Full Text] [Related]
12. Genetic testing for breast and ovarian cancer: implications for life insurance. Lemaire J; Subramanian K; Asch DA LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344 [TBL] [Abstract][Full Text] [Related]
13. Genetic oncology testing is complex, but coverage and reimbursement don't have to be. James LP Am J Manag Care; 2019 Aug; 25(9 Spec No.):SP288-SP289. PubMed ID: 31442013 [No Abstract] [Full Text] [Related]
14. Exploring barriers to payer utilization of genetic counselors. Doyle N; Cirino A; Trivedi A; Flynn M J Genet Couns; 2015 Feb; 24(1):122-33. PubMed ID: 25138080 [TBL] [Abstract][Full Text] [Related]
15. Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Balmaña J; Sanz J; Bonfill X; Casado A; Rué M; Gich I; Díez O; Sabaté JM; Baiget M; Alonso MC Int J Cancer; 2004 Nov; 112(4):647-52. PubMed ID: 15382046 [TBL] [Abstract][Full Text] [Related]
16. USPSTF recommends BRCA testing in women based on familial history. Dangi-Garimella S Am J Manag Care; 2014 Mar; 20(5 Spec No.):E6. PubMed ID: 25618620 [No Abstract] [Full Text] [Related]
17. Genetic testing creates new versions of ancient dilemmas. Klitzman R N Y Times Web; 2006 Jan; ():F5. PubMed ID: 16429628 [No Abstract] [Full Text] [Related]
18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
19. Genesurance Counseling: Genetic Counselors' Roles and Responsibilities in Regards to Genetic Insurance and Financial Topics. Brown S; Puumala S; Leonhard J; Bell M; Flanagan J; Dean LW; Stein Q J Genet Couns; 2018 Aug; 27(4):800-813. PubMed ID: 29204809 [TBL] [Abstract][Full Text] [Related]
20. The cost of genetic testing for ocular disease: who pays? Capasso JE Curr Opin Ophthalmol; 2014 Sep; 25(5):394-9. PubMed ID: 25010001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]